2010Unpublished venueRequires access

Assessment of Novel Molecular Prognostic Markers in Chronic Lymphocytic Leukemia

Bin Kaderi, Mohamed Arifin

Open publisher page 0 citations

Abstract

The clinical course of chronic lymphocytic leukemia (CLL) is highly heterogeneous, which has prompted the search for biomarkers that can predict prognosis in this disease. The IGHV gene mutation st ...

About this research paper

What this paper is about

The clinical course of chronic lymphocytic leukemia (CLL) is highly heterogeneous, which has prompted the search for biomarkers that can predict prognosis in this disease. The IGHV gene mutation st ...

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The clinical course of chronic lymphocytic leukemia (CLL) is highly heterogeneous, which has prompted the search for biomarkers that can predict prognosis in this disease. The IGHV gene mutation st ...

Key concepts: IGHV@, Chronic lymphocytic leukemia, Leukemia, Medicine, Mutation, Gene, Immunology, Cancer research

Related papers

Back to paper searchBrowse research topicsOriginal source
Assessment of Novel Molecular Prognostic Markers in Chronic Lymphocytic Leukemia — Research Paper | ScholarLens